Fifth Third Bancorp Has $11.77 Million Position in CVS Health Corporation $CVS

Fifth Third Bancorp reduced its position in CVS Health Corporation (NYSE:CVS) by 7.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 156,143 shares of the pharmacy operator’s stock after selling 12,827 shares during the quarter. Fifth Third Bancorp’s holdings in CVS Health were worth $11,772,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Koshinski Asset Management Inc. boosted its position in CVS Health by 40.6% in the second quarter. Koshinski Asset Management Inc. now owns 6,933 shares of the pharmacy operator’s stock valued at $478,000 after buying an additional 2,003 shares in the last quarter. Chicago Partners Investment Group LLC raised its position in CVS Health by 15.1% in the second quarter. Chicago Partners Investment Group LLC now owns 16,587 shares of the pharmacy operator’s stock valued at $1,144,000 after purchasing an additional 2,176 shares during the last quarter. Beverly Hills Private Wealth LLC boosted its stake in shares of CVS Health by 30.6% during the second quarter. Beverly Hills Private Wealth LLC now owns 6,065 shares of the pharmacy operator’s stock valued at $418,000 after purchasing an additional 1,421 shares in the last quarter. Stephens Inc. AR increased its stake in shares of CVS Health by 12.0% in the second quarter. Stephens Inc. AR now owns 30,620 shares of the pharmacy operator’s stock valued at $2,112,000 after buying an additional 3,285 shares during the period. Finally, Lyell Wealth Management LP bought a new position in CVS Health in the 2nd quarter valued at approximately $212,000. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the subject of several analyst reports. Argus lowered their target price on CVS Health from $91.00 to $90.00 and set a “buy” rating for the company in a research report on Wednesday, January 28th. Wolfe Research boosted their price objective on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, December 8th. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Wall Street Zen downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Finally, Jefferies Financial Group upped their price objective on shares of CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Nineteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $94.91.

CVS Health Stock Performance

NYSE:CVS opened at $78.12 on Wednesday. CVS Health Corporation has a 1 year low of $58.35 and a 1 year high of $85.15. The business has a fifty day simple moving average of $78.67 and a two-hundred day simple moving average of $76.56. The company has a market capitalization of $99.39 billion, a P/E ratio of 56.61, a P/E/G ratio of 0.82 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The firm had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same quarter in the prior year, the business posted $1.19 earnings per share. The business’s quarterly revenue was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. On average, analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is presently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.